Drug Research
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company retained...
Press Releases
Glenmark becomes the first pharmaceutical company in India to...
In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the launch of antiviral drug Favipiravir (brand...
Press Releases
Sharp Expands Commercial Packaging Capabilities to UK Facility
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has invested £1 million in a commercial expansion project...
Press Releases
EDQM provides COVID-19 vaccine developers with free access to...
The EDQM is committed to supporting vaccine developers during the coronavirus disease (COVID-19) pandemic – as well as contributing to the wider global effort to...
Clinical Trials
Imperial College London to begin human testing of new...
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an effective...
Press Releases
Jazz Pharma Gets Approval for Zepzelca in the U.S....
The U.S. FDA approved Jazz Pharmaceuticals and its partner PharmaMar’s Zepzelca (lurbinectedin) for adults with metastatic small cell lung cancer (SCLC) whose disease has progressed...
Drug Research
Saiba AG Selects AGC Biologics to Develop and Produce...
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.